title: [A carcinoid with cecal localization. Apropos a case].
abstract: An observed case of carcinoid tumor of the large-bowel in a 68-year-old woman leads to an analysis of the clinical-diagnostic and therapeutic aspects of this rare gastrointestinal tumour. Carcinoid tumour represents 0.8-1.5% of malignant digestive tumours, in 6% of cases it is localized in large-bowel and in 2-3% in cecal-bowel. In our experience there is no specific symptoms and diagnosis was based on postoperative histopathologic analysis. Right hemicolectomy with lymphadenectomy performed and the operative specimen included a 7 cm diameter tumour, which had narrowed the lumen by 80% and infiltrated ileocecal valve. Carcinoid tumour presents considerable problems of diagnosis because symptoms are aspecific. Diagnosis is possible only in patients with high urinary levels of 5-HIAA, in presence of carcinoid syndrome and by endoscopic biopsy when tumour infiltrated gastrointestinal mucosa. False negative cases are frequent in small carcinoids ( < 2 cm) because the tumour tissues are covered by integral mucosa. C.T., ultrasonography and angiography play a primary role in the diagnosis of this tumour but octreotide scintigraphy is very important for tumour and metastases localization in consequence of its ability to demonstrate somatostatin receptor positive tumours. Radical surgery is the only treatment in very little carcinoids to prevent metastases risk. Determinant risk factors are: primary size, localization, serosal penetration. In patients with any of these risk factors, resection with regional lymphadenectomy is recommended. Other prognostic factors include histologic differentiation, the presence of macroscopic residual disease after initial surgery and level of 5-HIAA in urine. We think that neither adjuvant chemotherapy, or radiotherapy may play a significant role in this neoplasm. Many authors report considerable unsuccessful with this treatment and it is used mainly for palliation. At present, the medical treatment of inoperable gastrointestinal carcinoid consist in association with interferon alpha and octreotide. During this treatment the size of the tumour is stable: reduction of symptoms and 5-HIAA urinary levels are noted.
authors.affiliation: Dipartimento di Chirurgia, Università degli Studi, Catania.
authors.forename: A
authors.initials: A
authors.lastname: Chisari
authors.forename: M
authors.initials: M
authors.lastname: Nicolosi
authors.forename: S
authors.initials: S
authors.lastname: Compagnone
authors.forename: F
authors.initials: F
authors.lastname: Tornambene
authors.forename: G
authors.initials: G
authors.lastname: Pulvirenti
authors.forename: G
authors.initials: G
authors.lastname: Deodato
mesh_terms: D000368:Aged; D002276:Carcinoid Tumor / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D002430:Cecal Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery; D002432:Cecum / Q000473:pathology / Q000601:surgery; D002763:Cholecystectomy; D003082:Colectomy / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans
vernacular_title: Il carcinoide a localizzazione cecale. A proposito di un caso.